Publication
Patents
Invited Lectures
Priz & Award
for Student
JH Kim, C Lee, M Lee, H Wang, K Kim, SJ Park, I Yoon, J Jang, H Zhao, HK Kim, NH Kwon, SJ Jeong, HC Yoo, JS Yang, MY Lee, CW Lee, J yun, SJ Oh, JS Kang, SA Martinis, KY Hwang, M Guo, G Han, JM Han*, S Kim*, Control of Leucine-dependent mTORC1 Pathway through Chemical Intervention of Leucyl-tRNA synthetase and RagD GTPase Interaction, Nature Communications, 8(1):732, 2017 (IF=12.124) (*Co-corresponding authors)
MR Kim, JH Jang, CS Park, T-K Kim, Y-J Kim, J Chung, H Shim, IH Nam, JM Han, S Lee, Identification of the Sixth Ig-like Domain of VCAM-1 as a Novel Therapeutic Target in Lung Cancer Cell Invasion, International Journal of Molecular Sciences, 18, 566, 2017 (IF=3.257)
JS Lim, R Gopalappa, SH Kim, S Ramakrishna, M Lee, WI Kim, J Kim, SM Park, J Lee, JH Oh, HD Kim, CH Park, JS Lee, S Kim, DS Kim, JM Han, HC Kang, HH Kim, JH Lee, Somatic mutations in TSC1 and TSC2 cause focal cortical dysplasia, The American Journal of Human Genetics, 100, 454-472, 2017 (IF=10.8)
A Motzik, E Amir, T Erlich, J Wang, B-G Kim, JM Han, J H Kim, H Nechushtan, M Guo, E Razin and S Tshori, Post translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cells, Oncogene, 36, 4732-4738, 2017 (IF=7.937)
2017
MS Yoon, K Son, E Arauz, JM Han, S Kim, J Chen, Leucyl-tRNA synthetase activates Vps34 in amino acid-sensing mTORC1 signaling, Cell Reports, 2016 Aug, 9;16(6): 1510-1517 (IF=7.87)
MK Yum, JS Kang, AE Lee, YW Jo, JY Seo, HA Kim, YY Kim, JW Seong, EB Lee, JH Kim, JM Han, S Kim, YY Kong, AIMP2 controls intestinal stem cell compartments and tumorigenesis by modulating Wnt/β-catenin signaling, Cancer Res, 2016 Aug, 1;76 (15):4559-4568 (IF=8.556)
DG Kim, JY Lee, JH Lee, HY Cho, BS Kang, SY Jang, MH Kim, M Guo, JM Han, SJ Kim, S Kim, Oncogenic Mutation of AIMP2/p38 Inhibits Its Tumor Suppressive Interaction with Smurf2, Cancer Res, 76(11): 3422-3436, 2016 (IF=8.556)
2016
JS Lim, KC Nguyen, JM Han, IS Jang, C Fabian, KA Cho, Direct regulation of TLR5 expression by caveolin-1, Mol Cells, 38(12): 1111-1117, 2015 (IF=2.67)
JS Lim JS, KC Nguyen, CT Nguyen, IS Jang, JM Han, C Fabian, SE Lee, JH Rhee, KA Cho, Flagellin-dependent TLR5/caveolin-1 as a promising immune activator in immunosenescence, Aging Cell, 14(5): 907-915, 2015 (IF=5.76)
2015
JH Kim, JH Lee, MC Park, I Yoon, K Kim, M Lee, HS Choi, JM Han*, S Kim*, AIMP1 negatively regulates adipogenesis by inhibiting PPARgamma, J. Cell Sci. 127: 4483-4493, 2014 (Co-corresponding authors) (IF=5.432)
DG Kim, JY Lee, NH Kwon, P Fang, Q Zhang, J Wang, NL Young, M Guo, HY Cho, AU Mushtaq, YH Jeon, JW Choi, JM Han, HW Kang, JE Joo, Y Hur, W Kang, H Yang, DH Nam, MS Lee, JW Lee, ES Kim, A Moon, K Kim, D Kim, EJ Kang, Y Moon, KH Rhee, BW Han, JS Yang, G Han, WS Yang, C Lee, MW Wang, S Kim, Chemical inhibition of pronetastatic lysyl-tRNA synthetase-laminin receptor interaction, Nat. Chem. Biol. 10(1): 29-34, 2014 (IF=12.996)
JH Kim, JM Han*, S Kim, Protein-protein interactions and multi-component complexes of aminoacyl-tRNA synthetases, Top. Curr. Chem. 344:119-144, 2014 (corresponding author) (IF=4.464)
2014
HS Lee, DG Kim, YS Oh, NH Kwon, JY Lee, D Kim, SH Park, JH Song, S Lee, JM Han, BJ Park, J Lee, S Kim, Chemical suppression of an oncogenic splicing variant of AIMP2 induces tumor regression, Biochem. J. 2013 (IF=3.562)
JS Kim, Y Lee, MY Lee, J Shin, JM Han, EG Yang, M-H Yu, S Kim, D Hwang, C Lee, Multiple reaction monitoring of multiple low-abundance transcription factors in whole lung cancer cell lysates J. Proteome Res. 12(6):2582-2596, 2013 (IF=5.001)